Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,197 | 61 | 88.4% |
| Education | $287.99 | 3 | 11.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $355.98 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $310.74 | 7 | $0 (2024) |
| Esperion Therapeutics, Inc. | $283.70 | 2 | $0 (2022) |
| Incyte Corporation | $267.60 | 9 | $0 (2024) |
| Merck Sharp & Dohme LLC | $267.05 | 7 | $0 (2024) |
| Coherus Biosciences Inc. | $148.12 | 1 | $0 (2024) |
| Exelixis Inc. | $135.00 | 1 | $0 (2024) |
| Eisai Inc. | $123.19 | 5 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $77.64 | 3 | $0 (2024) |
| TAIHO ONCOLOGY, INC. | $77.32 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,202 | 62 | AstraZeneca Pharmaceuticals LP ($355.98) |
| 2022 | $283.70 | 2 | Esperion Therapeutics, Inc. ($283.70) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $36.15 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/06/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $24.75 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.62 | General |
| 12/03/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Oncology | ||||||
| 11/09/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $28.63 | General |
| Category: Oncology / Rare Diseases | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | VPRIV (Biological) | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: GENETIC DISEASE | ||||||
| 10/25/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: Oncology | ||||||
| 10/18/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $15.99 | General |
| Category: Hematology/Oncology | ||||||
| 10/15/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $7.97 | General |
| Category: Hematology/Oncology | ||||||
| 10/11/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $23.11 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Oncology | ||||||
| 10/08/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Oncology | ||||||
| 10/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.06 | General |
| 10/04/2024 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.00 | General |
| 10/01/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $14.53 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 113 | 482 | $116,076 | $30,378 |
| 2022 | 2 | 73 | 168 | $37,336 | $9,977 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 71 | 333 | $70,929 | $18,721 | 26.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 42 | 149 | $45,147 | $11,657 | 25.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 41 | 104 | $20,696 | $5,515 | 26.6% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 32 | 64 | $16,640 | $4,463 | 26.8% |
About Meizhu Chen
Meizhu Chen is a Family healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2021. The National Provider Identifier (NPI) number assigned to this provider is 1770152969.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Meizhu Chen has received a total of $2,485 in payments from pharmaceutical and medical device companies, with $2,202 received in 2024. These payments were reported across 64 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,197).
As a Medicare-enrolled provider, Chen has provided services to 186 Medicare beneficiaries, totaling 650 services with total Medicare billing of $40,355. Data is available for 2 years (2022–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Brooklyn, NY
- Active Since 06/22/2021
- Last Updated 09/11/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1770152969
Products in Payments
- NEXLIZET (Drug) $283.70
- KEYTRUDA (Biological) $267.05
- ENHERTU (Biological) $208.92
- LOQTORZI (Biological) $148.12
- ERLEADA (Drug) $138.77
- CABOMETYX (Drug) $135.00
- TAGRISSO (Drug) $125.00
- MONJUVI (Drug) $124.05
- Lenvima (Drug) $123.19
- IMBRUVICA (Drug) $99.00
- LONSURF (Drug) $77.32
- AYVAKIT (Drug) $64.78
- XPOVIO (Drug) $60.34
- KRAZATI (Drug) $56.78
- NINLARO (Drug) $50.65
- DARZALEX (Biological) $50.04
- Enhertu (Drug) $47.50
- JAKAFI (Drug) $44.55
- VERZENIO (Drug) $43.99
- Stivarga (Drug) $27.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Brooklyn
Susan Weiss, Np, NP
Family — Payments: $20,923
Ms. Abigail Hunter, Fnp, FNP
Family — Payments: $18,034
Seida Velija
Family — Payments: $15,903
Ami Lam
Family — Payments: $15,616
Christina Lao
Family — Payments: $15,127
Mrs. Kelly Morris, Fnp, FNP
Family — Payments: $8,415